Cancer Home > Panitumab
Were you looking for information about Panitumumab? Panitumab is a common misspelling of panitumumab.
Panitumumab (Vectibix®) is a medication that is available by prescription only. It is approved for treating a type of colorectal cancer that has a certain protein called epidermal growth factor receptor (EGFR) on the surface of the cancer cells. Panitumumab works by binding to this protein, which helps slow down the growth of the cancer cells. A healthcare provider will administer the drug using an intravenous (IV) infusion every 14 days.
(Click Panitumumab for more information about how it works, side effects to look out for during treatment, and when and how the medication is administered. You can also click any of the links in the box to the right for specific information.)